Stock AMIX AUTONOMIX MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Autonomix Medical, Inc.

Equities

AMIX

US05330T1060

Delayed Nasdaq
Other stock markets
 12:39:59 2024-06-03 pm EDT 		5-day change 1st Jan Change
2.14 USD -6.14% Intraday chart for Autonomix Medical, Inc. +3.88% 0.00%
Apr. 25 Autonomix Enters into Agreement with Noisefigure Research, Inc. to Develop Next Generation of Its Proprietary Microchip CI
Apr. 16 Autonomix Medical Secures US Patent for Catheter-Based Technology to Treat Cancer-Related Pain MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial
Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update
Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series
Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip
Autonomix Enters into Agreement with Noisefigure Research, Inc. to Develop Next Generation of Its Proprietary Microchip
Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
Autonomix Medical Inc Covered in Benzinga Article Highlighting Innovative Nerve Treatment Tech
Autonomix Medical Secures US Patent for Catheter-Based Technology to Treat Cancer-Related Pain
Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation
Autonomix Medical, Inc. Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation
Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker
Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference
 Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024
Autonomix Appoints Jennifer Cook as Chief Business Officer
Autonomix Appoints Jennifer Cook as Chief Business Officer
Autonomix Medical, Inc.(NasdaqCM:AMIX) added to S&P TMI Index
Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AMIX Stock
  4. News Autonomix Medical, Inc.
  5. Other languages